Interview: Kairos Pharma CEO John Yu on ENV105’s potential & partnerships for growth
While cancer treatment is progressing at a fast rate the world over with new targeted drugs being launched, immunotherapy and radiation, therapy resistance continues to remain an obstacle in the…